From the Atlantic Highlands Herald
Thomas R. Calcagni, Acting Director of the New Jersey Division of Consumer Affairs, announced that a public hearing will be held Monday, July 11, a necessary step to make permanent New Jersey’s ban on designer drugs labeled as “bath salts
New Jersey is believed to be the third state in the nation to take expedited administrative action banning all six chemicals used in designer drugs labeled as “bath salts.” New Jersey’s ban took effect with an Order of the Acting Director, signed by Calcagni on Wednesday, April 27. The order classifies the six chemicals as Schedule I Controlled Dangerous Substances under New Jersey’s CDS Act, thereby subjecting them to the strictest level of state control. Manufacture, distribution, sale, or possession is now a third-degree crime, subject to fines of up to $25,000 and three- to five-years imprisonment.
The Order of the Acting Director lists the following chemicals as Schedule I Controlled Dangerous Substances in New Jersey:
3,4 – Methylenedioxypyrovalerone (MDPV)
4 – Methylmethcathinone (Mephedrone, 4-MMC)
3,4 – Methylenedioxymethcathinone (Methylone, MDMC)
4 – Fluoromethcathinone (Flephedrone, 4-FMC)
3 – Fluoromethcathinone (3-FMC)
4 – Methoxymethcathinone (Methedrone, bk-PMMA, PMMC)
The contents of individual packets of designer drugs labeled as “bath salts” vary, but have been found to include at least one of these chemicals. The chemicals are synthetic derivatives of cathinone, which is a Schedule I CDS under Federal law.